search
Back to results

Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome (PARAVENT)

Primary Purpose

Acute Respiratory Distress Syndrome

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Ventilatory adjustments by nurses
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Respiratory Distress Syndrome focused on measuring Acute respiratory distress syndrome, ARDS, Paramedical care protocol, Mortality

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age ≥ 18 years Intensive care hospitalization; Intubation with artificial ventilation; ARDS evolving for less than 72 hours. ARDS criteria according to the Berlin definition, as follows: Exposure to a risk factor for ARDS or onset/aggravation of pulmonary symptoms within the previous 7 days ; Respiratory distress not fully explained by cardiac failure or volume overload, with exclusion of hydrostatic edema in the absence of exposure to a risk factor for ARDS; Hypoxemia with PaO2/FiO2 ratio < 300 mm Hg under PEEP ≥ 5 cmH2O ; Bilateral opacities on chest X-ray, lung ultrasound or chest CT, not fully explained by pleural effusions, atelectasis or nodules. Blood pressure monitoring Affiliation to the social security system. Written informed consent (patient, relative) or inclusion in emergency situation. Exclusion Criteria: Long-term oxygen therapy; Pneumothorax or drained pleurisy; Documented pulmonary embolism; Intracranial hypertension; ARDS refractory to inclusion, i.e.: i) oxygen partial pressure on inspired oxygen fraction a ratio (PaO2/FiO2) <80 mm Hg or plateau pressure (Pplat) > 32 cmH2O despite optimization of mechanical ventilation (tidal volume (Vt) set at 6 mL/kg weight predicted by height, FiO2 ≥80% and positive expiratory pressure (PEEP) ≥10 cmH2O) and despite the use of complementary therapies (including prone and/or inhaled nitric oxide); or ii) pH <7. 25 with PaCO2 ≥60 mm Hg; ARDS evolving for more than 72 hours with intubation and mechanical ventilation; Patient deprived of liberty; Patient under legal protection (guardianship or curatorship); Known pregnancy or breast-feeding (a pregnancy test will be performed prior to inclusion in patients of childbearing age).

Sites / Locations

  • Assistance Publique-Hôpitaux de Paris service de santé publique

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental group

Control group

Arm Description

Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.

The ventilator settings are adjusted in line with the centre's usual practice. No change from usual management of acute respiratory distress syndrome.

Outcomes

Primary Outcome Measures

Mortality rate and number of days without mechanical ventilation
The primary endpoint will be a combination of mortality and the number of days without mechanical ventilation at D28. This composite criterion will be prioritised so that survival is given priority in the analysis over the shorter duration of mechanical ventilation.

Secondary Outcome Measures

Mesure of tidal volume ventilation
Mesure of plateau pressure
Mesure of positive end-expiratory pressure (PEEP)
Mesure of FiO2
Oxygenation
arterial blood gases and SpO2
Number of days without mechanical ventilation
Number of days without catecholamine
Number of days without continuous sedation
Duration of mechanical ventilation .
from intubation to successful extubation
Occurrence of mechanically ventilated pneumothorax
Duration of Acute respiratory distress syndrome
defined as the day on which the 1st test of spontaneous ventilation was performed
Duration of weaning from mechanical ventilation
measured as the time between the 1st test of spontaneous ventilation and successful extubation (patient alive and without reintubation within 7 days of extubation).
Number of participants with rescue therapy
Rate of re-intubation
Rate of use of non-invasive ventilation and curative high-flow oxygen therapy
Tracheostomy rate
Length of stay in intensive care and in hospital.
Number of deaths in ICU and hospital
Number of nurses trained in paramedical protocol per center.

Full Information

First Posted
July 12, 2023
Last Updated
September 8, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT06039215
Brief Title
Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome
Acronym
PARAVENT
Official Title
Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome: Prospective, Multicenter, Randomized, Controlled, Open-label, Phase III, Cluster Trial With Sequential Permutation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 1, 2023 (Anticipated)
Primary Completion Date
August 1, 2025 (Anticipated)
Study Completion Date
August 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Acute respiratory distress syndrome (ARDS) is a frequent pathology in intensive care (around 10% of patients admitted to intensive care and almost a quarter of patients on mechanical ventilation) and a serious one, with a hospital mortality rate of 40%. The main measures that have an effect on mortality in ARDS involve adjustments to the ventilator, known as protective ventilation. In the most severe patients, adjuvant measures such as prone positioning and the use of curarisation in the initial phase of the disease can improve survival. All these measures have been included in the latest national and international recommendations. However, a vast observational study carried out in 50 countries revealed low compliance with these recommendations. More than a third of patients did not receive protective ventilation, and the majority did not receive prone positioning when this was indicated. During weaning from artificial ventilation, it has been widely demonstrated that replacing clinician judgement with the implementation of paramedical care protocols improved weaning and significantly reduced the duration of artificial ventilation. Therefore, investigators hypothesize that the implementation of a paramedical care protocol for ventilation in the acute phase of ARDS improves compliance with recommendations and thus reduces mortality and the duration of artificial ventilation. However, implementation of such a protocol requires operational training for all the nurses in the participating departments. Simulation appears to be the training method of choice, as it is a teaching technique that enables technical and non-technical skills to be passed on with good retention of what has been learnt, as well as assessing what has been learnt. To make it possible to train several dozen nurses within a tight timescale, a partially dematerialized simulation model incorporating innovative e-learning tools will be developed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Respiratory Distress Syndrome
Keywords
Acute respiratory distress syndrome, ARDS, Paramedical care protocol, Mortality

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
This is a prospective, multicenter, randomized, controlled, open-label, phase III, stepped wedge cluster randomized design. This experimental design involves the sequential implementation of an intervention in the clusters included over several periods. The order in which the clusters received the intervention was determined by drawing lots; at the end of the study, all the clusters received the intervention at some point and were observed during a pre- and post-intervention control period (each cluster "is its own control").
Masking
None (Open Label)
Allocation
Randomized
Enrollment
540 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The ventilator settings are adjusted in line with the centre's usual practice. No change from usual management of acute respiratory distress syndrome.
Intervention Type
Other
Intervention Name(s)
Ventilatory adjustments by nurses
Other Intervention Name(s)
Post-intervention period
Intervention Description
Respirator settings are adjusted by nurses according to a pre-established care protocol that complies with international recommendations. The nurse assesses the patient's respiratory status and readjusts the artificial respirator settings if necessary, at least twice a day.
Primary Outcome Measure Information:
Title
Mortality rate and number of days without mechanical ventilation
Description
The primary endpoint will be a combination of mortality and the number of days without mechanical ventilation at D28. This composite criterion will be prioritised so that survival is given priority in the analysis over the shorter duration of mechanical ventilation.
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Mesure of tidal volume ventilation
Time Frame
Up to Day 7
Title
Mesure of plateau pressure
Time Frame
Up to Day 7
Title
Mesure of positive end-expiratory pressure (PEEP)
Time Frame
Up to Day 7
Title
Mesure of FiO2
Time Frame
Up to Day 7
Title
Oxygenation
Description
arterial blood gases and SpO2
Time Frame
Up to Day 7
Title
Number of days without mechanical ventilation
Time Frame
Up to Day 28
Title
Number of days without catecholamine
Time Frame
Up to Day 28
Title
Number of days without continuous sedation
Time Frame
Up to Day 28
Title
Duration of mechanical ventilation .
Description
from intubation to successful extubation
Time Frame
Up to Day 28
Title
Occurrence of mechanically ventilated pneumothorax
Time Frame
Up to Day 28
Title
Duration of Acute respiratory distress syndrome
Description
defined as the day on which the 1st test of spontaneous ventilation was performed
Time Frame
UP to Day 28
Title
Duration of weaning from mechanical ventilation
Description
measured as the time between the 1st test of spontaneous ventilation and successful extubation (patient alive and without reintubation within 7 days of extubation).
Time Frame
Up to Day 28
Title
Number of participants with rescue therapy
Time Frame
Up to Day 28
Title
Rate of re-intubation
Time Frame
Up to Day 28
Title
Rate of use of non-invasive ventilation and curative high-flow oxygen therapy
Time Frame
Up to Day 28
Title
Tracheostomy rate
Time Frame
Up to Day 28
Title
Length of stay in intensive care and in hospital.
Time Frame
Up to day 28
Title
Number of deaths in ICU and hospital
Time Frame
Up to Day 28
Title
Number of nurses trained in paramedical protocol per center.
Time Frame
Up to 26 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Intensive care hospitalization; Intubation with artificial ventilation; ARDS evolving for less than 72 hours. ARDS criteria according to the Berlin definition, as follows: Exposure to a risk factor for ARDS or onset/aggravation of pulmonary symptoms within the previous 7 days ; Respiratory distress not fully explained by cardiac failure or volume overload, with exclusion of hydrostatic edema in the absence of exposure to a risk factor for ARDS; Hypoxemia with PaO2/FiO2 ratio < 300 mm Hg under PEEP ≥ 5 cmH2O ; Bilateral opacities on chest X-ray, lung ultrasound or chest CT, not fully explained by pleural effusions, atelectasis or nodules. Blood pressure monitoring Affiliation to the social security system. Written informed consent (patient, relative) or inclusion in emergency situation. Exclusion Criteria: Long-term oxygen therapy; Pneumothorax or drained pleurisy; Documented pulmonary embolism; Intracranial hypertension; ARDS refractory to inclusion, i.e.: i) oxygen partial pressure on inspired oxygen fraction a ratio (PaO2/FiO2) <80 mm Hg or plateau pressure (Pplat) > 32 cmH2O despite optimization of mechanical ventilation (tidal volume (Vt) set at 6 mL/kg weight predicted by height, FiO2 ≥80% and positive expiratory pressure (PEEP) ≥10 cmH2O) and despite the use of complementary therapies (including prone and/or inhaled nitric oxide); or ii) pH <7. 25 with PaCO2 ≥60 mm Hg; ARDS evolving for more than 72 hours with intubation and mechanical ventilation; Patient deprived of liberty; Patient under legal protection (guardianship or curatorship); Known pregnancy or breast-feeding (a pregnancy test will be performed prior to inclusion in patients of childbearing age).
Facility Information:
Facility Name
Assistance Publique-Hôpitaux de Paris service de santé publique
City
Créteil
State/Province
Creteil
ZIP/Postal Code
94010
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Assistance Publique-Hôpitaux de Paris service de santé publique
Phone
0145178638
Email
samia.baloul@aphp.fr

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION

Learn more about this trial

Paramedical Protocol for Ventilation in Acute Respiratory Distress Syndrome

We'll reach out to this number within 24 hrs